Loss-of-function FLG mutations are associated with reduced history of acne vulgaris in a cohort of patients with atopic eczema of Bangladeshi ancestry in East London

Background Acne vulgaris (AV) is the eighth most common nonfatal disease globally. Previous work identified an association between AV and increased filaggrin (FLG) protein expression in the follicular epidermis, but further work did not find a clear link between loss-of-function (LoF) FLG gene mutations and protection from AV.Objectives To explore any association between AV and FLG LoF mutations in a cohort of genotyped patients of Bangladeshi ancestry with atopic eczema (AE) in East London.Methods A retrospective notes review was performed on 245 patients who had been genotyped for FLG LoF mutations and undergone clinical assessment. A chi 2-test or Fisher's exact test was used to determine differences in AV history between FLG LoF genotype groups.Results We found a significant reduction in history of AV in patients with AE with FLG LoF mutations (19 of 82) relative to those without FLG mutations (47 of 129) (23% vs. 36.4%; P = 0.02). We showed a nonsignificant reduction in AV diagnosis in patients with impaired barrier function (measured by transepidermal water loss) and palmar hyperlinearity. We found that patients with severe AE were less likely to have a history of AV only if they had an existing FLG LoF mutation (P = 0.02).Conclusions In the context of AE, our work suggests that FLG LoF mutations protect patients from developing AV. We aimed to explore any association between acne vulgaris (AV) and FLG loss-of-function (LoF) mutations, in a cohort of genotyped patients of Bangladeshi ancestry with atopic eczema (AE) in East London. In the context of AE, our work suggests that FLG LoF mutations protect patients from developing AV. Patients with severe AE were less likely to have a history of AV only if they had an existing FLG LoF mutation.